fbpx

Latest News


Take charge after stroke

Taking Charge after Stroke

April 21, 2020

Take Charge – a low-cost, person-centred, self-directed rehabilitation intervention after stroke – improved health-related quality of life and independence. Read the full Open-Access paper here: https://bit.ly/TaCAS-study Be sure to tune into Dr Harry McNaughton presenting an online Webinar on April 30th 2020 at 0900 London time, 1800 AEST: https://zoom.us/webinar/register/WN_S6rcZpcbSlua8zD5Ja4WEA Video presentations...

Read more about this

MRINZ joins the fight against COVID-19 with 3 new trials

Clinical trials in New Zealand supporting the global fight against COVID-19

April 17, 2020

We have been hard at work establishing and contributing to major internationally-significant trials in the fight against COVID-19. “The clinical trials will assess multiple potential therapeutic agents including hydroxychloroquine, one of a number of drugs gaining media attention as a potential treatment for COVID-19”. MRINZ Director Professor Richard Beasley The...

Read more about this

Server upgrade & maintenance

April 10, 2020

Our servers were struggling with the overwhelming (and wonderful) response to our ‘How big is your bubble?’ pandemic survey. This caused it to glitch for some people when filling it out. We have been busy upgrading the servers and performing maintenance overnight, but as of Friday 10th April morning, we...

Read more about this

From Osler to Personalised Medicine in obstructive airways disease

April 6, 2020

We know that the features used to diagnose asthma and COPD overlap. For patients who have features of both, the diagnostic label of ‘asthma COPD overlap’ (ACO) is sometimes used. This has several definitions, and there is no consensus on how best to manage patients with this label, limiting its...

Read more about this

COVID-19 announcement - studies paused

Outpatient studies are paused to focus on COVID-19 and ICU studies

March 21, 2020

New Zealand has had its first 2 cases of probable community transmission of COVID-19, in other words, cases which are not linked to travel. We have been preparing for this, and as planned, will pause all outpatient studies for now to protect our volunteers and staff. Over the past few...

Read more about this

History and future of SABA in asthma by Dr Ciléin Kearns

The history and future of SABA in asthma care

March 2, 2020

Beta-agonists have been used to treat asthma for thousands of years, originally as a naturally occurring compound in the Chinese herbal medicine ‘ma-huang’. They have the ability to relax smooth muscle in the airways when it spasms or tightens, which makes breathing easier when asthma symptoms flare. In our latest...

Read more about this

Medicinal cannabis - what are patients asking their GP?

Medicinal Cannabis – what are patients asking their GP’s?

February 24, 2020

Around the world, there is a growing interest in the use of cannabis as a medicine. In New Zealand, a Medicinal Cannabis Scheme is currently being established to increase access to medicinal cannabis products. In light of this, we decided to ask kiwi General Practitioners (GPs) what patients have been...

Read more about this

Inhaled steroids may have similar effects, both positive and negative, to steroids taken by mouth for asthma

February 17, 2020

Asthma symptoms and flare-ups are caused by inflammation of the airways. To treat this, anti-inflammatory medication such as corticosteroids are often prescribed. Most people with asthma are treated with corticosteroids using an inhaler (inhaled corticosteroids). Usually, this would be at a dose which mostly has an effect within the airways....

Read more about this

Optimal asthma control: time for a new target

February 10, 2020

Day-to-day asthma treatment is widely based on a stepwise approach where care can be ‘stepped up’ to control symptoms, and ‘stepped down’ after a period of symptom control. We have written a review of potential problems with this approach.  Firstly, this model can only achieve ’total control’ of symptoms for...

Read more about this

The AIR algorithm: a new approach to asthma care based on evidence of better outcomes, safety, and ease of use for patients

February 3, 2020

We have proposed a new treatment model for day-to-day asthma care: the anti-inflammatory reliever therapy based algorithm (AIR algorithm for short), based on a 2-in-1 combination inhaler. Day-to-day asthma care usually involves taking two types of medicines: Maintenance: regular scheduled treatment to control asthma symptoms and reduce the risk of...

Read more about this